26 results
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
to serve on the audit committee. Our board of directors has designated Philippe Calais as an “audit committee financial expert,” as defined under
8-K
EX-10.1
mfjgt46od1
14 Apr 23
TransCode Therapeutics Announces Equity Investment from White Lion Capital to Help Fund Development of TTX-MC138 for Treatment of Glioblastomas
7:19am
PRE 14A
ursvmdvcuii
31 Mar 23
Preliminary proxy
4:17pm
DEF 14A
v0kth
2 May 22
Definitive proxy
4:02pm
8-K
EX-99.1
6qzg5ucs
1 Apr 22
TransCode Therapeutics Reports 2021 Results; Provides Business Update
4:00pm
8-K
EX-99.1
qt1283 ppqwft6vou74
23 Aug 21
TransCode Therapeutics Reports Business Progress and Second Quarter 2021 Financial Results
4:55pm
424B4
7639syshb 8pwa5q4mms
9 Jul 21
Prospectus supplement with pricing info
5:22pm